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CORRESPONDENCE 
The bactericidal activity of gatifloxacin in 
plasma and urine [l] 
Clin Microbiol Infect 1998; 4: 731 
Suitable pharmacodynamic parameters which predict 
successful clinical outcome could optimize the design 
of clinical studies. Serum and urinary bactericidal titers 
may be supportive in this respect, if these parameters 
reflect the in vivo situation of a specific infectious status 
as closely as possible. 
When performing such studies, special care has to 
be taken in choosing the right media for diluting the 
body fluids (plasma or urine). The NCCLS method [2] 
applied by the authors to determine the serum 
bactericidal activity does not recommend any specific 
media, and Mueller-Hinton broth (MHB) was used in 
their study to dilute the plasma samples. After several 
dilution steps there is almost no serum present. The 
results achieved can therefore be predicted from the 
serum concentration of the active drug and the minimal 
bactericidal concentration (MBC) of a pathogen 
determined in vitro in MHB. Since the influence of the 
specific biological medium is no longer included, such 
parameters do not add new information above the 
routine pharmacokinetic results and the in vitro 
antibacterial activity of an investigated drug. 
For the evaluation of new compounds in the treat- 
ment of urinary tract infections, we used as a urine 
bactericidal test a modification of various methods 
published [3]. Very early, we recognized that the proper 
medium for diluting the urine samples was urine and 
not any other synthetic medium (such as MHB), 
because we could demonstrate that the urinary 
bactericidal titers (UBTs) determined with urine as 
diluent were three to two dilution steps lower than 
those with MHB as diluent [4]. In a lengthy personal 
communication during a meeting with the sponsors for 
developing gratifloxacin, we brought the principal 
author’s attention to this finding and supplied him with 
our past publications describing the method we 
developed. 
The authors [l] used urine as diluent but standard- 
ized the pH to 6, which may lead to more reproducible 
results but again does not reflect the biological variation 
we have to face. Therefore, in our studies we used the 
specific subject’s individual antibiotic-free urine as 
diluent [4-61. Taking this into consideration, the range 
of results may become wider but better reflects the 
biological reality. For clinical purposes, the lowest titers 
and not the median ones should determine the dose 
necessary for treatment to include also those patients 
with relatively low bactericidal activity. 
Since the method of UBT is not standardized yet, 
comparisons of results are only allowed between studies 
using exactly the same method. The relevance of the 
absolute titers concerning outcome is also not estab- 
lished. Therefore, UBTs can only be considered as a 
relative comparison between alternative drugs or 
regimens. In clinical studies the predictive value of 
UBTs should be evaluated. 
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Reading Haemophilus influenzae Etest macrolide and 
amoxycillin susceptibilities: inter-observer variation 
appears to be small 
Clin Microbiol Infect 1998; 4: 731-733 
Tande et al. [l] and others [2] reported on significant 
inter-laboratory variations when using the Etest (AB 
Biodisk, Solna, Sweden) to judge the susceptibility of 
common respiratory pathogens to various antibiotics. 
This test is now used widely both for special studies 
and, increasingly, for routine diagnostic bacteriology 
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[3,4]. Problems were thought to result principally from 
methodological variations between laboratories (such 
as in Etest strip storage, plate inoculation, drying and 
incubation length), and some have noted unclear zones 
with macrolide testing of Haernophilus injuenzae, perhaps 
resulting from high inoculum and slow bacterial 
growth [2]. These organisms often have drug MICs 
close to the breakpoints recommended for clinical 
interpretation, and even small differences in the results 
can significantly alter the designation of isolates as 
‘sensitive’or ‘resistant’ [ 1,5]. We recently undertook a 
susceptibility study of 316 isolates of H .  injuenzae 
from significant lower respiratory tract infection in 
North Yorkshire, testing azithromycin, clarithromycin, 
erythromycin and amoxycillin by Etest; the two authors 
took the opportunity to read the test plates inde- 
pendently so that results could be compared as a 
measure of observer variation. Full results of the study 
will be presented elsewhere. 
Briefly, the 316 isolates in 1 year’s catchment from 
sputum in our routine diagnostic laboratories were 
saved at -70°C and resuscitated for the study; fresh 
cultures were suspended in broth to 0.5 McFarland 
density and inoculated for confluent growth onto 
IsoSensitest agar supplemented with 20 mg/L NAD 
and 5% whole horse blood; susceptibility to the drugs 
was judged by Etest with 18 h of incubation at 37°C in 
5% COz. The authors had little previous experience in 
the use of Etests, and followed the reading procedures 
as described and illustrated by the manufacturers; the 
stacks of plates from the study were read in parallel 
independently at  different benches in the laboratory 
and results recorded separately. 
With this highly supportive medium and COZ 
incubation, the growth of all isolates was good and 
results were clearcut and easy to read. The findings 
of the two observers are compared in Table 1, with 
interpretation of breakpoints according to the BSAC 
Working Party guidelines [6]. The ranges of MIC were 
identical between observers with each drug, while 
MICios and MIC90s were also identical for each 
macrolide tested and very similar for amoxycillin. The 
MIC’s of these drugs with H .  inpuenzae are close to 
the recommended breakpoints, and discrepancies in 
designation of resistance for the whole collection of 
isolates between observers were 1.9% for azithromycin, 
4.5% for clarithromycin, 4.4% for erythromycin and 
0.3% for amoxycillin. Overall, although observer A 
tended to find MICs a little higher than observer B, 
with none of the drugs did the difference between 
readers in rates of resistance reach statistical signifi- 
cance: by comparison of the number of resistant and 
non-resistant MIC counts on each antibiotic between 
observers using McNemar’s test, p-values were: azithro- 
mycin, 0.304, clarithromycin 0.164, erythromycin 
0.189 and amoxycillin 0.916. 
The results therefore show a good concordance 
between the two observers. Whether this finding can 
be extrapolated with validity to other observers judging 
other organisms and drugs with the Etest is uncertain, 
but the results suggest that this could be so, insofar as 
they were derived from tests on fastidious organisms 
with workers inexperienced at reading the Etest. We 
believe that previous reports [1,2] are correct in 
ascribing inter-laboratory discrepancies with Etest 
results more to niethodological differences than to 
observer variations. 
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Table 1 Susceptibility of 316 isolates of H. infitrenzae to four antibiotics by Etest: comparison of results from two 
independent observers 
MIC (nig/L) Azithromycin Clarithroniycin Erythromycin Amoxvcillin 
Observcr A 
M 1 niinum 
Maximum 
MI(:w 
MIGo 
‘XI of isolates resittmt 
Olxrrver H 
Minimum 
Maximum 
MICsii 
‘% of iqolates resistant 
M1Cw 
‘High-level’ breakpoints [6] 
0.064 
1 .o 
3.0 
6.6 
2256 
0.064 
1 .(I 
3.0 
4.7 
24.0 
2256 
0 .  (13 2 
6.0 
24.0 
22.2 
2256 
0.032 
6.0 
24.0 
17.7 
216.0 
2256 
0.125 
4.0 
16.0 
25.6 
2256 
0.125 
4.0 
16.0 
21.2 
28.0 
2256 
0 .  I 9 0  
0.5 
24.0 
17.1 
2256 
0.190 
0..5 
16.0 
17.1 
21.0 
2256 
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Cefpirome-vancomycin combination in 
methicillin-resistant Staphylococcus aureus infection 
Clin Microbiol Infect 1998; 4: 733-734 
In the treatment of severe staphylococcal infections, 
especially in neutropenic patients or when multiple 
antibiotic resistance is present, vancomycin is often 
used with other antistaphylococcal agents such as 
rifampicin, fosfomycin or fusidic acid. In a previous 
study, we described the in vitro bactericidal activity 
of the cefpirome-vancomycin combination against 
both methicillin-susceptible and methicillin-resistant 
Staphylococcus aureus (MRSA) and coagulase-negative 
Staphylococcus strains [l]. 
An 8-year-old girl, who had cystic fibrosis 
diagnosed during the first year of life, had pulmonary 
colonization with a homogeneously methicillin-resistant 
Staphylococcus aureus strain. This had been present for a 
year at counts of 10z-lO1l CFU/mL in monthly sputum 
specimens, with consistent susceptibility to antibiotics. 
Pseudomonas aeruginosa was never detected. The girl had 
been treated for 6 months with the following com- 
binations: (1) co-trimoxazole (30 mg/kg per day) plus 
fosfomycin (80 mg/kg per day) plus vancomycin 
(80 mg/kg per day) for 1 month; (2) vancomycin plus 
cefotaxime (100 mg/kg per day) for 3 weeks; (3) 
pristinamycin (1 60 mg/kg per day) plus aerosolized 
vancomycin (750 mg per day) for 2 months; (4) vanco- 
mycin plus imipenem (100 mg/kg per day) for 3 weeks; 
and (5) pristinamycin (160 mg/kg per day) for 6 weeks. 
Vancomycin concentrations in serum were regularly 
monitored. With this treatment, the Staphylococcus 
anreus count in sputum decreased to lo2 CFU/mL but 
the strain was never eradicated. During January 1997, 
the patient experienced a new febrile episode with 
a right inferior lobe atelectasis and hypoxemia. The 
C-reactive protein concentration was 77 mg/L (normal 
values: 0-8 mg/L). Blood cultures remained sterile. 
Sputum cultures revealed the presence of three different 
bacterial isolates: an MRSA isolate (5 X lo6 CFU/mL), 
a derepressed mutant of Enterobacter cloacae (7 X 
lo5 CFU/mL), a P-lactamase-producing strain of 
Haemophilus infuenzae (4 X 106 CFU/mL) and Asper- 
gillusfurnigatus (10 CFU/mL). The E. cloacae strain was 
susceptible to ce$irome, cefepime, imipenem, colistin, 
quinolones and cotrimoxazole, whereas the S. aureus 
isolate was resistant to all these antibiotics. The clinical 
significance of A. furnigatus was confirmed by positive 
serology. 
We performed a time kill assay of the in vitro effect 
of cefpironie-vancomycin against the Staphylococcus 
aureus isolate, using the methods previously described 
[l]. The minimum inhibitory concentrations (MICs) 
were 64 mg/L of cefpirome and 1 mg/L of vanco- 
mycin. In the time kill assay, the lowest combination 
exhibiting a bactericidal effect (>3 loglo CFU/mL 
reduction) was 8 mg/L of cefpirome (0.125 X MIC) and 
1 mg/L (1 XMIC) of vancomycin (Table 1). This 
cefpirome concentration can be achieved in the lungs 
We decided to treat the girl with a combination of 
intravenous cefpirome 100 mg/kg per day and vanco- 
mycin 40 mg/kg per day in three divided doses. 
Two days later, the fever had decreased and sputum 
culture revealed lo2 CFU/mL of Staphylococcus aureus, 
10' CFU/mL. of A. furnigatus and absence of E. cloacae. 
O n  day 4, the girl became apyrexial and the C-reactive 
protein concentration was 87 mg/L. At day 15, sputum 
culture showed eradication of Staphylococcus aureus, E .  
cloacae and H .  intuenzae; Stenotrophomonas maltophilia 
P I .  
